Pilot Study of the Pharmacokinetic Profile of Deferiprone Sustained-Release Formulation in Healthy Volunteers
Status:
Completed
Trial end date:
2014-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study was to evaluate the pharmacokinetic and safety profile of the
sustained-release formulation of deferiprone under both fasting and fed conditions, and
evaluate the relative bioavailability of this sustained-release formulation when compared to
immediate-release formulation of deferiprone under fasting conditions.